{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:16Z","timestamp":1791918916970,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["20203BBGL73149"],"award-info":[{"award-number":["20203BBGL73149"]}],"id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03722-y","type":"journal-article","created":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T22:01:27Z","timestamp":1728856887000},"page":"2005-2013","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Combining serum CDK1 with tumor markers for the diagnosis of small cell lung cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"Kexin","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0227-8561","authenticated-orcid":false,"given":"Liming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,13]]},"reference":[{"issue":"10299","key":"3722_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398(10299):535\u201354. https:\/\/doi.org\/10.1016\/S0140-6736(21)00312-3.","journal-title":"Lancet"},{"issue":"1","key":"3722_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/CCO.0000000000000703","volume":"33","author":"F Wu","year":"2021","unstructured":"Wu F, Wang L, Zhou C. Lung cancer in China: current and prospect. Curr Opin Oncol. 2021;33(1):40\u20136. https:\/\/doi.org\/10.1097\/CCO.0000000000000703.","journal-title":"Curr Opin Oncol"},{"key":"3722_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.11.035","author":"R Roskoski","year":"2018","unstructured":"Roskoski R. Cyclin-dependent protein serine\/threonine kinase inhibitors as anticancer drugs. Pharmacol Res. 2018. https:\/\/doi.org\/10.1016\/j.phrs.2018.11.035.","journal-title":"Pharmacol Res"},{"issue":"4","key":"3722_CR4","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/1878-0261.12882","volume":"15","author":"X Zhao","year":"2021","unstructured":"Zhao X, Kim IK, Kallakury B, Chahine JJ, Iwama E, Pierobon M, et al. Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up-regulation. Mol Oncol. 2021;15(4):1130\u201345. https:\/\/doi.org\/10.1002\/1878-0261.12882.","journal-title":"Mol Oncol"},{"issue":"9","key":"3722_CR5","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s12094-021-02575-z","volume":"23","author":"Z Huang","year":"2021","unstructured":"Huang Z, Shen G, Gao J. CDK1 promotes the stemness of lung cancer cells through interacting with Sox2. Clin Transl Oncol. 2021;23(9):1743\u201351. https:\/\/doi.org\/10.1007\/s12094-021-02575-z.","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"3722_CR6","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.6004\/jnccn.2021.0058","volume":"19","author":"AKP Ganti","year":"2021","unstructured":"Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D\u2019Amico TA, et al. Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(12):1441\u201364. https:\/\/doi.org\/10.6004\/jnccn.2021.0058.","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"3722_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3779\/j.issn.1009-3419.2011.10.08","volume":"14","author":"J Wang","year":"2011","unstructured":"Wang J, Zhang S. Advances on treatment of limited-disease small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2011;14(10):811\u20138. https:\/\/doi.org\/10.3779\/j.issn.1009-3419.2011.10.08.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"6","key":"3722_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3760\/cma.j.cn112152-20220413-00255","volume":"44","author":"H Baohui","year":"2022","unstructured":"Baohui H. Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2022 edition). Zhonghua Zhong Liu Za Zhi. 2022;44(6):457\u201390. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20220413-00255.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"3722_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.phrs.2018.11.035","volume":"139","author":"R Roskoski Jr","year":"2019","unstructured":"Roskoski R Jr. Cyclin-dependent protein serine\/threonine kinase inhibitors as anticancer drugs. Pharmacol Res. 2019;139:471\u201388. https:\/\/doi.org\/10.1016\/j.phrs.2018.11.035.","journal-title":"Pharmacol Res"},{"issue":"11","key":"3722_CR10","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/s41416-023-02468-8","volume":"129","author":"G Massacci","year":"2023","unstructured":"Massacci G, Perfetto L, Sacco F. The Cyclin-dependent kinase 1: more than a cell cycle regulator. Br J Cancer. 2023;129(11):1707\u201316. https:\/\/doi.org\/10.1038\/s41416-023-02468-8.","journal-title":"Br J Cancer"},{"key":"3722_CR11","doi-asserted-by":"publisher","first-page":"e8215","DOI":"10.7717\/peerj.8215","volume":"7","author":"L Zhang","year":"2019","unstructured":"Zhang L, Peng R, Sun Y, Wang J, Chong X, Zhang Z. Identification of key genes in non-small cell lung cancer by bioinformatics analysis. PeerJ. 2019;7:e8215. https:\/\/doi.org\/10.7717\/peerj.8215.","journal-title":"PeerJ"},{"issue":"4","key":"3722_CR12","doi-asserted-by":"publisher","first-page":"300060520980647","DOI":"10.1177\/0300060520980647","volume":"49","author":"Z Xing","year":"2021","unstructured":"Xing Z, Wang X, Liu J, Zhang M, Feng K, Wang X. Expression and prognostic value of CDK1, CCNA2, and CCNB1 gene clusters in human breast cancer. J Int Med Res. 2021;49(4):300060520980647. https:\/\/doi.org\/10.1177\/0300060520980647.","journal-title":"J Int Med Res"},{"issue":"8","key":"3722_CR13","doi-asserted-by":"publisher","first-page":"11115","DOI":"10.1007\/s13277-016-4991-4","volume":"37","author":"K Bednarek","year":"2016","unstructured":"Bednarek K, Kiwerska K, Szaumkessel M, Bodnar M, Kostrzewska-Poczekaj M, Marszalek A, et al. Recurrent CDK1 overexpression in laryngeal squamous cell carcinoma. Tumour Biol. 2016;37(8):11115\u201326. https:\/\/doi.org\/10.1007\/s13277-016-4991-4.","journal-title":"Tumour Biol"},{"issue":"2","key":"3722_CR14","doi-asserted-by":"publisher","first-page":"300060519897508","DOI":"10.1177\/0300060519897508","volume":"48","author":"M Li","year":"2020","unstructured":"Li M, He F, Zhang Z, Xiang Z, Hu D. CDK1 serves as a potential prognostic biomarker and target for lung cancer. J Int Med Res. 2020;48(2):300060519897508. https:\/\/doi.org\/10.1177\/0300060519897508.","journal-title":"J Int Med Res"},{"key":"3722_CR15","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1186\/1471-2407-14-951","volume":"14","author":"WW Sung","year":"2014","unstructured":"Sung WW, Lin YM, Wu PR, Yen HH, Lai HW, Su TC, et al. High nuclear\/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients. BMC Cancer. 2014;14:951. https:\/\/doi.org\/10.1186\/1471-2407-14-951.","journal-title":"BMC Cancer"},{"issue":"4","key":"3722_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41419-019-1528-y","volume":"10","author":"Y Kuang","year":"2019","unstructured":"Kuang Y, Guo W, Ling J, Xu D, Liao Y, Zhao H, et al. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130\/STAT3 signaling pathway. Cell Death Dis. 2019;10(4):297. https:\/\/doi.org\/10.1038\/s41419-019-1528-y.","journal-title":"Cell Death Dis"},{"issue":"51","key":"3722_CR17","doi-asserted-by":"publisher","first-page":"85235","DOI":"10.18632\/oncotarget.13252","volume":"7","author":"YX Shi","year":"2016","unstructured":"Shi YX, Zhu T, Zou T, Zhuo W, Chen YX, Huang MS, et al. Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma. Oncotarget. 2016;7(51):85235\u201343. https:\/\/doi.org\/10.18632\/oncotarget.13252.","journal-title":"Oncotarget"},{"issue":"8","key":"3722_CR18","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/JTO.0b013e318298762f","volume":"8","author":"R Hubaux","year":"2013","unstructured":"Hubaux R, Thu KL, Coe BP, MacAulay C, Lam S, Lam WL. EZH2 promotes E2F-driven SCLC tumorigenesis through modulation of apoptosis and cell-cycle regulation. J Thorac Oncol. 2013;8(8):1102\u20136. https:\/\/doi.org\/10.1097\/JTO.0b013e318298762f.","journal-title":"J Thorac Oncol"},{"issue":"22","key":"3722_CR19","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.7314\/apjcp.2014.15.22.9611","volume":"15","author":"B Wang","year":"2014","unstructured":"Wang B, He YJ, Tian YX, Yang RN, Zhu YR, Qiu H. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer. Asian Pac J Cancer Prev. 2014;15(22):9611\u20134. https:\/\/doi.org\/10.7314\/apjcp.2014.15.22.9611.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"3722_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000224628","volume":"30","author":"R Molina","year":"2009","unstructured":"Molina R, Aug\u00e9 JM, Bosch X, Escudero JM, Vi\u00f1olas N, Marrades R, et al. Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology. Tumour Biol. 2009;30(3):121\u20139. https:\/\/doi.org\/10.1159\/000224628.","journal-title":"Tumour Biol"},{"issue":"4","key":"3722_CR21","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.3892\/ol.2018.9158","volume":"16","author":"Y Oya","year":"2018","unstructured":"Oya Y, Yoshida T, Uemura T, Murakami Y, Inaba Y, Hida T. Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: A case report. Oncol Lett. 2018;16(4):4219\u201322. https:\/\/doi.org\/10.3892\/ol.2018.9158.","journal-title":"Oncol Lett"},{"issue":"6","key":"3722_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.7754\/Clin.Lab.2018.171132","volume":"64","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Yuan Y, Yang X, Lu Q, Lu X, Huang H. Age and gender-specific reference intervals for ProGRP in healthy Chinese Han Ethnic Adults using the Roche Cobas Immunoassay. Clin Lab. 2018;64(6):923\u20138. https:\/\/doi.org\/10.7754\/Clin.Lab.2018.171132.","journal-title":"Clin Lab"},{"issue":"2","key":"3722_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1724600819834235","volume":"34","author":"C Mauro","year":"2019","unstructured":"Mauro C, Passerini R, Spaggiari L, Galetta D, Radice D, Lentati P, et al. New and old biomarkers in the differential diagnosis of lung cancer: Pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21\u20131. Int J Biol Markers. 2019;34(2):163\u20137. https:\/\/doi.org\/10.1177\/1724600819834235.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"3722_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12291-012-0257-0","volume":"28","author":"I Ghosh","year":"2013","unstructured":"Ghosh I, Bhattacharjee D, Das AK, Chakrabarti G, Dasgupta A, Dey SK. Diagnostic role of tumour markers CEA, CA15-3, CA19-9 and CA125 in lung cancer. Indian J Clin Biochem. 2013;28(1):24\u20139. https:\/\/doi.org\/10.1007\/s12291-012-0257-0.","journal-title":"Indian J Clin Biochem"},{"issue":"3","key":"3722_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3349\/ymj.2013.54.3.643","volume":"54","author":"KJ Lee","year":"2013","unstructured":"Lee KJ, Yi SW, Chung MJ, Park SW, Song SY, Chung JB, et al. Serum CA 19\u20139 and CEA levels as a prognostic factor in pancreatic adenocarcinoma. Yonsei Med J. 2013;54(3):643\u20139. https:\/\/doi.org\/10.3349\/ymj.2013.54.3.643.","journal-title":"Yonsei Med J"},{"issue":"4","key":"3722_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3892\/mco.2014.286","volume":"2","author":"Y Ding","year":"2014","unstructured":"Ding Y, Xuan W, Chen C, Chen Z, Yang Z, Zuo Y, et al. Differences in carcinoembryonic antigen levels between colon and rectal cancer. Mol Clin Oncol. 2014;2(4):618\u201322. https:\/\/doi.org\/10.3892\/mco.2014.286.","journal-title":"Mol Clin Oncol"},{"issue":"10","key":"3722_CR27","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1515\/CCLM.2011.694","volume":"49","author":"J Trap\u00e9","year":"2011","unstructured":"Trap\u00e9 J, Filella X, Alsina-Donadeu M, Juan-Pereira L, Bosch-Ferrer \u00c1, Rigo-Bonnin R. Increased plasma concentrations of tumour markers in the absence of neoplasia. Clin Chem Lab Med. 2011;49(10):1605\u201320. https:\/\/doi.org\/10.1515\/CCLM.2011.694.","journal-title":"Clin Chem Lab Med"},{"key":"3722_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2017.12.020","volume":"194","author":"ZF Jiang","year":"2018","unstructured":"Jiang ZF, Wang M, Xu JL. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Life Sci. 2018;194:1\u20136. https:\/\/doi.org\/10.1016\/j.lfs.2017.12.020.","journal-title":"Life Sci"},{"issue":"4","key":"3722_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3892\/br.2016.612","volume":"4","author":"F Tas","year":"2016","unstructured":"Tas F, Bilgin E, Tastekin D, Erturk K, Duranyildiz D. Clinical significance of serum laminin levels in patients with lung cancer. Biomed Rep. 2016;4(4):485\u20138. https:\/\/doi.org\/10.3892\/br.2016.612.","journal-title":"Biomed Rep"},{"issue":"07","key":"3722_CR30","first-page":"1219","volume":"31","author":"L\u00fc Mingchuang","year":"2022","unstructured":"Mingchuang L\u00fc, Hongyan W. The expression significance of serum neuron specific enolase and gastrin releasing peptide precursor in small cell lung cance. Henan Med Res. 2022;31(07):1219\u201322.","journal-title":"Henan Med Res"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03722-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03722-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03722-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T06:03:38Z","timestamp":1745647418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03722-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,13]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["3722"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03722-y","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,13]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have no conflicts of interest to disclose. All database used in the article are available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This project has been approved by the Ethics Committee of the Second Affiliated Hospital of Nanchang University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided informed consent prior to their participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}